Shingles Vaccine Market By Vaccine Type (Recombinant Shingles Vaccine, Live Attenuated Shingles Vaccine), By Vaccine Composition (Monovalent Vaccines, Combination Vaccines), By Immunization Type (Preventive Vaccination, Therapeutic Vaccination), By Route of Administration (Intramuscular (IM), Subcutaneous (SC)), and By End User (Hospitals, Specialty Clinics, Vaccination Centers, Homecare Settings), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035

Published Date: Aug 2025 | Report ID: MI3507 | 210 Pages

Report Summary Table of Contents Segmentation FAQ Request Sample Report

Report Coverage:

By Vaccine Type

  • Recombinant Shingles Vaccine
  • Live Attenuated Shingles Vaccine

By Vaccine Composition

  • Monovalent Vaccines
  • Combination Vaccines

By Immunization Type

  • Preventive Vaccination
  • Therapeutic Vaccination

By Route of Administration

  • Intramuscular (IM)
  • Subcutaneous (SC)

By End User

  • Hospitals
  • Specialty Clinics
  • Vaccination Centers
  • Homecare Settings

By Region

North America

  • U.S.
  • Canada

Europe

  • U.K.
  • France
  • Germany
  • Italy
  • Spain
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Singapore
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America

Middle East & Africa

  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

List of Companies:

  • GlaxoSmithKline (GSK)
  • Merck & Co., Inc.
  • Pfizer Inc.
  • Moderna Inc.
  • Dynavax Technologies
  • Curevo Inc.
  • GeneOne Life Science
  • Jiangsu Recbio Technology Co., Ltd.
  • SK bioscience
  • CanSinoBIO
  • Changchun BCHT Biotechnology Co.
  • Vaccitech
  • Valneva SE
  • Bavarian Nordic
  • Johnson & Johnson

Maximize your value and knowledge with our 5 Reports-in-1 Bundle - over 40% off!

Our analysts are ready to help you immediately.

Request Bundle Pricing